(Q48650801)

13 February 2018

title

Regional distribution of somatostatin receptor binding and modulation of adenylyl cyclase activity in Alzheimer's disease brain (English)

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

28 October 2022

0 references

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

28 October 2022

6

B Winblad

1 reference

13 February 2018

lars nilsson

3

object named as

L. Nilsson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1684616

28 October 2022

author name string

L. Bergström

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1684616

28 October 2022

A. Garlind

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1684616

28 October 2022

I. Alafuzoff

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1684616

28 October 2022

C. J. Fowler

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1684616

28 October 2022

R. F. Cowburn

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1684616

28 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1684616

28 October 2022

publication date

1 October 1991

1 reference

13 February 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0022510X91901492?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

https://api.elsevier.com/content/article/PII:0022510X91901492?httpAccept=text/plain

28 October 2022

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

Journal of the Neurological Sciences

28 October 2022

published in

1 reference

13 February 2018

volume

105

1 reference

13 February 2018

issue

2

1 reference

13 February 2018

page(s)

225-233

1 reference

13 February 2018

Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

Somatostatin-like immunoreactivity within neuritic plaques.

28 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer's disease.

28 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

Somatostatin binding sites in human and monkey brain: localization and characterization.

28 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

Widespread reduction of somatostatin-like immunoreactivity in the cerebral cortex in Alzheimer's disease.

28 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

Somatostatin receptors and the modulation of adenylyl cyclase activity in Alzheimer's disease

28 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

Characterization and regional distribution of adenylyl cyclase activity from human brain

28 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

Cortical neurons immunoreactive with antisera against neuropeptide Y are altered in Alzheimer's-type dementia.

28 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

Distribution of altered hippocampal neurons and axons immunoreactive with antisera against neuropeptide Y in Alzheimer's-type dementia.

28 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

A quantitative assessment of somatostatin-like and neuropeptide Y-like immunostained cells in the frontal and temporal cortex of patients with Alzheimer's disease

28 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa

28 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

Modifications in the cortical regional distribution of choline acetyltransferase, somatostatin and somatostatin binding sites in the normal rat and following lesion of the nucleus basalis

28 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

Somatostatin concentrations and binding sites in human frontal cortex are differentially affected in Parkinson's disease associated dementia and in progressive supranuclear palsy

28 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

Alzheimer's disease: is there a problem beyond recognition?

28 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

Neurotransmitters in the cerebral cortex

28 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

Autoradiographic study of somatostatin receptors in the rat hypothalamus: validation of a GTP-induced desaturation procedure

28 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

Differential effects of somatostatin on adenylate cyclase as functional correlate for different brain somatostatin receptor subpopulations

28 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

Neuropeptide Y receptor binding sites in human brain. Possible alteration in Alzheimer's disease

28 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

Somatostatin immunoreactivity in neuritic plaques of Alzheimer's patients

28 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

[Coupling of inhibitory GTP binding protein to somatostatin receptors on rat cerebrocortical membranes]

28 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

Reduced basal and stimulated (isoprenaline, Gpp(NH)p, forskolin) adenylate cyclase activity in Alzheimer's disease correlated with histopathological changes

28 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

Location of neuronal tangles in somatostatin neurones in Alzheimer's disease

28 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type

28 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

Somatostatin inhibition of adenylate cyclase activity in different brain areas

28 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

Increases in muscarinic stimulated hydrolysis of inositol phospholipids in rat hippocampus following cholinergic deafferentation are not parallelled by alterations in cholinergic receptor density

28 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

Cerebrospinal fluid somatostatin correlates with spectral EEG variables and with parietotemporal cognitive dysfunction in Alzheimer patients

28 October 2022

34

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

Receptor binding of somatostatin-14 and somatostatin-28 in rat brain: differential modulation by nucleotides and ions.

28 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

Reduced brain somatostatin levels in Alzheimer's disease.

28 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

Alzheimer's disease: low cerebral somatostatin levels correlate with impaired cognitive function and cortical metabolism

28 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

Somatostatin receptors: distribution in rat central nervous system and human frontal cortex.

28 October 2022

38

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

Somatostatin-14 and somatostatin-28 inhibit calcium currents in rat neocortical neurons

28 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

Neuropeptide Y receptors and the inhibition of adenylate cyclase in the human frontal and temporal cortex

28 October 2022

40

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

Human cerebellar cortex possesses high affinity binding sites for [3H]somatostatin.

28 October 2022

41

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

Regional distribution of high-affinity [3H]somatostatin binding sites in the human brain.

28 October 2022

42

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

Autoradiographic visualization of binding sites for [3H]somatostatin in the rat brain

28 October 2022

43

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

Cortical somatostatinergic system not affected in Alzheimer's and Parkinson's diseases.

28 October 2022

44

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90149-2

28 October 2022

Identifiers

1 reference

13 February 2018

1 reference

13 February 2018